Skip to main content

Hitinder S. Gurm, MBBS, MD, FSCAI

Commentary
07/13/2009
The elderly and the very elderly are the most rapidly growing segment of the population in the Western world.1–3 The prevalence of coronary artery disease rises with age, and coronary revascularization is commonly performed in elderly...
The elderly and the very elderly are the most rapidly growing segment of the population in the Western world.1–3 The prevalence of coronary artery disease rises with age, and coronary revascularization is commonly performed in elderly...
The elderly and the very elderly...
07/13/2009
Journal of Invasive Cardiology
Commentary
01/07/2010
The fact that we are still debating the utility of the bare metal stent (BMS) in 2009 would have seemed unthinkable when the first drug-eluting stent (DES) was approved by the Food and Drug Administration for clinical use in the U.S. in 2003....
The fact that we are still debating the utility of the bare metal stent (BMS) in 2009 would have seemed unthinkable when the first drug-eluting stent (DES) was approved by the Food and Drug Administration for clinical use in the U.S. in 2003....
The fact that we are still...
01/07/2010
Journal of Invasive Cardiology
Commentary
02/24/2010
Bivalirudin is theoretically a promising alternative to unfractionated heparin (UFH). It is a direct thrombin inhibitor and has the ability to block circulating and clot-bound thrombin and prevent thrombin-mediated platelet activation.1...
Bivalirudin is theoretically a promising alternative to unfractionated heparin (UFH). It is a direct thrombin inhibitor and has the ability to block circulating and clot-bound thrombin and prevent thrombin-mediated platelet activation.1...
Bivalirudin is theoretically a...
02/24/2010
Journal of Invasive Cardiology
Commentary
10/24/2011
Contrast-induced nephropathy (CIN) continues to be one of the most common major adverse side effect of cardiac catheterization, and is associated with short- and long-term morbidity and mortality.1,2 This is particularly true in the...
Contrast-induced nephropathy (CIN) continues to be one of the most common major adverse side effect of cardiac catheterization, and is associated with short- and long-term morbidity and mortality.1,2 This is particularly true in the...
Contrast-induced nephropathy...
10/24/2011
Journal of Invasive Cardiology
Commentary
02/29/2012
Vascular access complications from diagnostic coronary angiography and percutaneous intervention are a major cause of morbidity and mortality. The use of vascular closure devices is common practice and their use to decrease complications is...
Vascular access complications from diagnostic coronary angiography and percutaneous intervention are a major cause of morbidity and mortality. The use of vascular closure devices is common practice and their use to decrease complications is...
Vascular access complications...
02/29/2012
Journal of Invasive Cardiology
Cover Story
11/05/2017
This is a simple tool that is easy to incorporate into clinical practice. Acknowledgement of the contrast threshold makes the entire cath lab staff cognizant of the importance of the contrast dosing to the patient and operators are able to...
This is a simple tool that is easy to incorporate into clinical practice. Acknowledgement of the contrast threshold makes the entire cath lab staff cognizant of the importance of the contrast dosing to the patient and operators are able to...
This is a simple tool that is...
11/05/2017
Cath Lab Digest
Original Contribution
12/27/2017
To evaluate the clinical features and outcomes of patients with anemia undergoing percutaneous peripheral vascular intervention (PVI) in a contemporary registry, we evaluated the differences in the clinical features and outcomes of patients...
To evaluate the clinical features and outcomes of patients with anemia undergoing percutaneous peripheral vascular intervention (PVI) in a contemporary registry, we evaluated the differences in the clinical features and outcomes of patients...
To evaluate the clinical...
12/27/2017
Journal of Invasive Cardiology
Original Contribution
03/15/2017
Recent data demonstrate that mortality of patients with ST-elevation myocardial infarction (STEMI) has not changed despite dramatic reduction in door-to-balloon times. Identifying potential areas in care that can be further optimized to...
Recent data demonstrate that mortality of patients with ST-elevation myocardial infarction (STEMI) has not changed despite dramatic reduction in door-to-balloon times. Identifying potential areas in care that can be further optimized to...
Recent data demonstrate that...
03/15/2017
Journal of Invasive Cardiology
Original Contribution
04/15/2017
We sought to describe trends in the use of preprocedural P2Y12 inhibitors and their clinical impact in patients undergoing percutaneous coronary intervention (PCI).
We sought to describe trends in the use of preprocedural P2Y12 inhibitors and their clinical impact in patients undergoing percutaneous coronary intervention (PCI).
We sought to describe trends in...
04/15/2017
Journal of Invasive Cardiology
10/06/2010
The Relative Renal Safety of Iodixanol and Low-Osmolar Contrast Media in Patients Undergoing Percutaneous Coronary Intervention Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
The Relative Renal Safety of Iodixanol and Low-Osmolar Contrast Media in Patients Undergoing Percutaneous Coronary Intervention Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
The Relative Renal Safety of...
10/06/2010
Journal of Invasive Cardiology